HONG KONG -- JD Health, the health care subsidiary of Chinese e-commerce giant JD.com, filed for an initial public offering to the Hong Kong Stock Exchange by Monday in a bid to raise $1.8 billion to $2.8 billion within the year.
JD Health operates the largest pharmaceutical retail website in China, and plans to use the fresh funds for research and development.